Exosome is involved in liver graft protection after remote ischemia reperfusion conditioning

Hepatobiliary Pancreat Dis Int. 2023 Oct;22(5):498-503. doi: 10.1016/j.hbpd.2022.04.004. Epub 2022 Apr 25.

Abstract

Background: Remote ischemic perconditioning (RIPerC) has been demonstrated to protect grafts from hepatic ischemia-reperfusion injury (IRI). This study investigated the role of exosomes in RIPerC of liver grafts in rats.

Methods: Twenty-five rats (including 10 donors) were randomly divided into five groups (n = 5 each group): five rats were used as sham-operated controls (Sham), ten rats were for orthotopic liver transplantation (OLT, 5 donors and 5 recipients) and ten rats were for OLT + RIPerC (5 donors and 5 recipients). Liver architecture and function were evaluated.

Results: Compared to the OLT group, the OLT + RIPerC group exhibited significantly improved liver graft histopathology and liver function (P < 0.05). Furthermore, the number of exosomes and the level of P-Akt were increased in the OLT + RIPerC group.

Conclusions: RIPerC effectively improves graft architecture and function, and this protective effect may be related to the increased number of exosomes. The upregulation of P-Akt may be involved in underlying mechanisms.

Keywords: Exosome; Ischemia-reperfusion injury; P-Akt; Remote ischemic perconditioning.

MeSH terms

  • Animals
  • Exosomes* / pathology
  • Ischemia
  • Liver / pathology
  • Liver / surgery
  • Liver Transplantation* / adverse effects
  • Proto-Oncogene Proteins c-akt
  • Rats
  • Reperfusion
  • Reperfusion Injury* / etiology
  • Reperfusion Injury* / pathology
  • Reperfusion Injury* / prevention & control

Substances

  • Proto-Oncogene Proteins c-akt